FEDERATED HERMES, INC. - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 83 filers reported holding ENZO BIOCHEM INC in Q1 2021. The put-call ratio across all filers is 4.25 and the average weighting 0.3%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q4 2022$189
-81.1%
1320.0%0.00%
Q3 2022$1,0000.0%1320.0%0.00%
Q2 2022$1,0000.0%132
-41.6%
0.00%
Q1 2022$1,0000.0%2260.0%0.00%
Q4 2021$1,0000.0%2260.0%0.00%
Q3 2021$1,0000.0%2260.0%0.00%
Q2 2021$1,0000.0%2260.0%0.00%
Q1 2021$1,0000.0%226
-3.4%
0.00%
Q4 2020$1,0000.0%234
-15.2%
0.00%
Q3 2020$1,0000.0%276
-2.1%
0.00%
Q2 2020$1,0000.0%282
-5.1%
0.00%
Q1 2020$1,0000.0%2970.0%0.00%
Q4 2019$1,0000.0%2970.0%0.00%
Q3 2019$1,0000.0%2970.0%0.00%
Q2 2019$1,0000.0%297
-2.6%
0.00%
Q1 2019$1,0000.0%3050.0%0.00%
Q4 2018$1,000
-75.0%
305
-71.4%
0.00%
Q3 2018$4,000
-55.6%
1,067
-36.1%
0.00%
Q2 2018$9,000
-90.2%
1,669
-90.1%
0.00%
Q1 2018$92,000
-92.9%
16,825
-89.4%
0.00%
-100.0%
Q4 2017$1,288,000
-22.0%
158,080
+0.3%
0.00%
-20.0%
Q3 2017$1,651,000
+25.6%
157,654
+32.5%
0.01%
+25.0%
Q2 2017$1,314,000
+43.8%
119,006
+8.9%
0.00%
+33.3%
Q1 2017$914,000
+9040.0%
109,244
+7465.4%
0.00%
Q4 2016$10,0000.0%1,444
-23.6%
0.00%
Q3 2016$10,0000.0%1,891
+16.4%
0.00%
Q2 2016$10,000
+233.3%
1,624
+120.4%
0.00%
Q1 2016$3,0000.0%7370.0%0.00%
Q4 2015$3,000
+200.0%
737
+98.1%
0.00%
Q3 2015$1,000
-50.0%
372
-38.3%
0.00%
Q2 2015$2,0000.0%6030.0%0.00%
Q1 2015$2,000
-71.4%
603
-55.6%
0.00%
Q3 2014$7,000
-12.5%
1,359
-10.4%
0.00%
Q2 2014$8,0001,5160.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q1 2021
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,736,719$9,414,00013.61%
HARBERT FUND ADVISORS, INC. 5,175,913$17,805,0008.40%
Evermore Global Advisors, LLC 2,605,607$8,963,0006.32%
KEMPNER CAPITAL MANAGEMENT INC. 95,476$328,0000.19%
CORRADO ADVISORS, LLC 46,816$161,0000.12%
MYDA Advisors LLC 35,000$120,0000.03%
Cutter & CO Brokerage, Inc. 29,827$103,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 258,700$890,0000.02%
Paradigm Financial Partners, LLC 18,000$62,0000.02%
Renaissance Technologies 3,340,864$11,493,0000.01%
View complete list of ENZO BIOCHEM INC shareholders